Safety and efficacy of adalimumab for moderate to severe crohn's disease in children

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 365-374.e2

  Hyams, Jeffrey S ^a   Griffiths, Anne ^b   Markowitz, James ^c   Baldassano, Robert N ^d   Faubion Jr , William A ^e   Colletti, Richard B ^f   Dubinsky, Marla ^g   Kierkus, Jaroslaw ^h   Rosh, Joel ⁱ   Wang, Yaqin ^j   Huang, Bidan ^j   Bittle, Barry ^j   Marshall, Michael ^j   Lazar, Andreas ^k  

^a Farmington   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Northwell Health   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

ⁱ Atlantic Health   (United States)

^j ABBOTT LABORATORIES   (United States)

^k ABBOTT GMBH AND CO KG   (Germany)

more..

Author keywords

Anti TNF Agent; Clinical Trial; Inflammatory Bowel Disease; Tumor Necrosis Factor

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

ADOLESCENT; ARTICLE; BLOOD TOXICITY; CHILD; CHILDHOOD DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEMYELINATING DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION; LIVER TOXICITY; LUPUS LIKE SYNDROME; LYMPHOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 84864287281     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.04.046     Document Type: Article

References (29)

1. J. Kelsen, R.N. Baldassano Inflammatory bowel disease: the difference between children and adults Inflamm Bowel Dis 14 Suppl 2 2008 S9 S11
2. E.I. Benchimol, K.J. Fortinsky, P. Gozdyra Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends Inflamm Bowel Dis 17 2011 423 439
3. A.M. Griffiths Specificities of inflammatory bowel disease in childhood Best Pract Res Clin Gastroenterol 18 2004 509 523 (Pubitemid 38667463)
4. C.G. Sauer, S. Kugathasan Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD Gastroenterol Clin North Am 38 2009 611 628
5. A.B. Ballinger, M.O. Savage, I.R. Sanderson Delayed puberty associated with inflammatory bowel disease Pediatr Res 53 2003 205 210 (Pubitemid 36177114)
6. A.M. Griffiths, P. Nguyen, C. Smith Growth and clinical course of children with Crohn's disease Gut 34 1993 939 943 (Pubitemid 23203116)
7. M.E. Kanof, A.M. Lake, T.M. Bayless Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease Gastroenterology 95 1988 1523 1527 (Pubitemid 19016210)
8. J. Markowitz, K. Grancher, J. Rosa Growth failure in pediatric inflammatory bowel disease J Pediatr Gastroenterol Nutr 16 1993 373 380 (Pubitemid 23143764)
9. J.S. Hyams, J.F. Markowitz Can we alter the natural history of Crohn disease in children? J Pediatr Gastroenterol Nutr 40 2005 262 272 (Pubitemid 40344089)
10. J. Markowitz, J. Hyams, D. Mack Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease Clin Gastroenterol Hepatol 4 2006 1124 1129 (Pubitemid 44311642)
11. J. Tung, E.V. Loftus Jr, D.K. Freese A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis Inflamm Bowel Dis 12 2006 1093 1100 (Pubitemid 44847465)
12. W.A. Faubion Jr, A. Bousvaros Medical therapy for refractory pediatric Crohn's disease Clin Gastroenterol Hepatol 4 2006 1199 1213 (Pubitemid 44512211)
13. S. Cucchiara, A. Morley-Fletcher "New drugs: kids come first": children should be included in trials of new biological treatments Inflamm Bowel Dis 13 2007 1165 1169 discussion 1176-1177
14. J. Hyams, W. Crandall, S. Kugathasan Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children Gastroenterology 132 2007 863 873 (Pubitemid 46454266)
15. J.S. Hyams, T. Lerer, A. Griffiths Long-term outcome of maintenance infliximab therapy in children with Crohn's disease Inflamm Bowel Dis 15 2009 816 822
16. Y. Rosenbach, C. Hartman, R. Shapiro Adalimumab treatment in children with refractory Crohn's disease Dig Dis Sci 55 2010 747 753
17. J.R. Rosh, T. Lerer, J. Markowitz Retrospective evaluation of the safety and effect of adalimumab therapy (RESEAT) in pediatric Crohn's disease Am J Gastroenterol 104 2009 3042 3049
18. F. Viola, F. Civitelli, G. Di Nardo Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease Am J Gastroenterol 104 2009 2566 2571
19. M.J. Wyneski, A. Green, M. Kay Safety and efficacy of adalimumab in pediatric patients with Crohn disease J Pediatr Gastroenterol Nutr 47 2008 19 25
20. R.K. Russell, M.L. Wilson, S. Loganathan A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease Aliment Pharmacol Ther 33 2011 946 953
21. J.S. Hyams, G.D. Ferry, F.S. Mandel Development and validation of a pediatric Crohn's disease activity index J Pediatr Gastroenterol Nutr 12 1991 439 447
22. J.M. Tanner, P.S. Davies Clinical longitudinal standards for height and height velocity for North American children J Pediatr 107 1985 317 329 (Pubitemid 15240782)
23. N. Gupta, A.G. Bostrom, B.S. Kirschner Gender differences in presentation and course of disease in pediatric patients with Crohn disease Pediatrics 120 2007 e1418 e1425
24. W.J. Sandborn, B.G. Feagan, S. Stoinov Certolizumab pegol for the treatment of Crohn's disease N Engl J Med 357 2007 228 238 (Pubitemid 47080387)
25. P.S. Kundhal, J.N. Critch, M. Zachos Pediatric Crohn Disease Activity Index: responsive to short-term change J Pediatr Gastroenterol Nutr 36 2003 83 89 (Pubitemid 41672624)
26. J.F. Colombel, W.J. Sandborn, P. Rutgeerts Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial Gastroenterology 132 2007 52 65 (Pubitemid 46108762)
27. S.B. Hanauer, W.J. Sandborn, P. Rutgeerts Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial Gastroenterology 130 2006 323 333
28. W.J. Sandborn, P. Rutgeerts, R. Enns Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial Ann Intern Med 146 2007 829 838 (Pubitemid 351650483)
29. J. Hyams, L. Damaraju, M. Blank Induction and maintenance therapy with infliximab for children with moderate-to-severe ulcerative colitis Clin Gastroenterol Hepatol 10 2012 391 399